Inhibition of POSTN disrupts GSC maintenance, inhibits the recruitment of immunosuppressive microglia, suppresses regulatory T-cell (Treg) development and function, and suppresses GBM growth, suggesting that targeting POSTN may effectively increase the efficacy of GBM treatment. Here, POSTN is linked to glioblastoma.